2023. Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s273. DOI:https://doi.org/10.25251/skin.7.supp.273.